About N.B. Life Science Private Limited
Data last updated:
N.B. Life Science Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2015PTC098561. Its GSTIN is 36AAECN9078Q1ZH (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Bhadraiah Kore and Kopperi Uma Maheshwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No 2 – 2 – 215/15/92 Macha Bollaram, Hyderabad, Telangana, India – 500010.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.53 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹61,440 (net margin 2%) and EBITDA of ₹87,359 (EBITDA margin 2.9%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nblifescience.com.
Company details
Contact details
N.B. Life Science Private Limited's registered office is in Hyderabad, Telangana. Its website is nblifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDoor No 2 – 2 – 215/15/92 Macha Bollaram, Hyderabad, Telangana, India – 500010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of N.B. Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of N.B. Life Science is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of N.B. Life Science Private Limited, buy the company report.
Financials of N.B. Life Science Private Limited
FY 2025 filings availableN.B. Life Science Private Limited reported revenue of ₹30.53 Lakh (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 29% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 318% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87,359 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹61,440 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of N.B. Life Science Private Limited, buy the company report.
Board of directors of N.B. Life Science Private Limited
N.B. Life Science has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhadraiah Kore | Director | 20 Apr 2015 | 11 Years 6 Months | Current |
| Kopperi Uma Maheshwar | Director | 05 Aug 2017 | 9 Years 2 Months | Current |
| Rukmangadhar Kopperi | Director | 05 Aug 2017 | 9 Years 2 Months | Current |
Peer comparison
N.B. Life Science Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Erinle Pharma Private Limited | ₹30.64 Lakh (FY 2019) | -24.0% | Bangalore, Karnataka, India | |||
| Arnium Health Care Private Limited | ₹30.6 Lakh (FY 2022) | 173.0% | New Delhi, Delhi, India | |||
| N.B. Life Science Private Limitedthis company | ₹30.53 Lakh (FY 2025) | ₹61,440 | 2% | 29.0% | Hyderabad, Telangana, India | |
| Ackrose Pharmaceuticals Private Limited | ₹30.44 Lakh (FY 2025) | -35.0% | Delhi, India |
To see the full peer comparison of N.B. Life Science Private Limited, buy the company report.
Auditor
N.B. Life Science Private Limited is audited by RAJSEKHARA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJSEKHARA & ASSOCIATES | FY 2019 | 011714S |
Shareholding
The shareholding of N.B. Life Science Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of N.B. Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving N.B. Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for N.B. Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
N.B. Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECN9078Q1ZH | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of N.B. Life Science Private Limited, buy the company report.
Recent activity
N.B. Life Science Private Limited has 7 board changes on record since 2015: 3 appointments and 4 cessations. The latest: Laxman Seripalli ceased to be Director on 01 Nov 2019.
Frequently asked questions
N.B. Life Science is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 April 2015 (11+ years old) and is registered under CIN U74900TG2015PTC098561.
N.B. Life Science has 3 current directors:
- Bhadraiah Kore - Director
- Kopperi Uma Maheshwar - Director
- Rukmangadhar Kopperi - Director
The latest financial statements of N.B. Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of N.B. Life Science is 36AAECN9078Q1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of N.B. Life Science is U74900TG2015PTC098561. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
N.B. Life Science was incorporated on 20 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of N.B. Life Science by revenue are Erinle Pharma Private Limited, Arnium Health Care Private Limited, Ackrose Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Laxman Seripalli ceased to be Director on 01 Nov 2019. Kopperi Uma Maheshwar ceased to be Additional Director on 30 Sep 2017. Rukmangadhar Kopperi ceased to be Additional Director on 30 Sep 2017. N.B. Life Science has 7 board changes on record in total.
N.B. Life Science can be reached through the website nblifescience.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of N.B. Life Science is at Door No 2 – 2 – 2151592 Macha Bollaram, Hyderabad, Telangana, India – 500010.
N.B. Life Science operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
